FDA – appsane

Menu

Latest stories

Gaps In Clinical Studies Present New Opportunities For Puerto Rico
From fatal eyedrops to mislabeled melatonin, why the FDA is letting the public down
Pharmaceutical Stock Collection: FDA Approves PFE & JNJ Drugs, EU Approves ABBV Migraine Drug
Alert as the FDA fast-tracks the first antipsychotic drug for agitation in dementia
FDA Grants Orphan Drug Designation to NXP800 for Cholangiocarcinoma
The FDA Hits Integra with a Warning Letter
The FDA warns about weight loss drug scams
$FDA Grants Elratamab Accelerated Approval for Relapsed or Refractory Multiple Myeloma$

FDA Grants Elratamab Accelerated Approval for Relapsed or Refractory Multiple Myeloma

Back to Top

Close